What does CUSIP 09061G101 represent in this 13F holders report?

CUSIP 09061G101 is the security identifier for BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock used to aggregate holder disclosures.

How many institutions held BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in Q2 2020?

516 institutional investors reported BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class: Equity / Common Stock
Total 13F shares: 180,885,676
Total 13F value: $22,304,634,235
Share change: +4,136,442
Put/Call ratio: 79%
SEC-reported price per share: $123.34
Number of holders: 516
Value change: +$749,303,824
Number of buys: 288
Number of sells: 221
Shares outstanding: 192,632,743

Security key

09061G101

Report period

Q2 2020

Institutions

516

Top holders

BMRN full security history Ownership snapshot Full 13F holder table BIOMARIN PHARMACEUTICAL INC SEC filings BIOMARIN PHARMACEUTICAL INC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital Research Global I...

Disclosed value leader

Capital Research Global I...

Comparable rows

15/15

Latest evidence

31 Mar 2020

13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.

Comparable ownership Top 5

Capital Research Global Investors 11%

PRIMECAP MANAGEMENT CO/CA/ 9.2%

VANGUARD GROUP INC 8.8%

BlackRock Finance, Inc. 7.6%

JENNISON ASSOCIATES LLC 4.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	11%	$1,862,430,000 22,040,618 shares	—	31 Mar 2020
PRIMECAP MANAGEMENT CO/CA/	13F Company 13F	9.2%	$1,504,925,000 17,809,767 shares	—	31 Mar 2020
VANGUARD GROUP INC	13F Company 13F	8.8%	$1,432,786,000 16,956,050 shares	—	31 Mar 2020
BlackRock Finance, Inc.	13F Company 13F	7.6%	$1,233,338,000 14,595,710 shares	—	31 Mar 2020
JENNISON ASSOCIATES LLC	13F Company 13F	4.3%	$694,122,000 8,214,463 shares	—	31 Mar 2020
BAKER BROS. ADVISORS LP	13F Company 13F	3.9%	$641,295,000 7,589,294 shares	—	31 Mar 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

516

180,885,676

Rows available

516

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

489

Q2 2020 holders

516

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q2 2020 value	Value change	Value Chg %